Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cytosorbents Corp CTSO

Healthcare Medical Devices
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in intensive care (ICU) and cardiac surgery using blood purification via its proprietary polymer adsorption technology. The Company’s flagship product, CytoSorb, is an extracorporeal cytokine absorber, designed to reduce the cytokine storm or cytokine release syndrome that could otherwise cause massive... see more

Recent & Breaking News (NDAQ:CTSO)

CytoSorbents to Present at the Maxim Group - Haitong Securities Inaugural Healthcare Investor and Partnering Conference

PR Newswire March 6, 2017

CytoSorbents Reports Record Quarterly and Full-Year 2016 Revenue

PR Newswire March 3, 2017

Earnings Scheduled For March 3, 2017

Benzinga.com  March 3, 2017

CytoSorbents to Present at 37th Annual Cowen and Company Healthcare Conference

PR Newswire March 2, 2017

CytoSorbents to Report Fiscal 2016 Operating and Financial Results

PR Newswire February 24, 2017

CytoSorbents to Present at the 2nd Annual Disruptive Growth & Healthcare Conference

Accesswire February 8, 2017

CytoSorbents to Present at the 19th Annual BIO CEO & Investor Conference

PR Newswire February 7, 2017

CytoSorbents Launches VetResQ™ for U.S. Veterinary Market

PR Newswire January 20, 2017

Fresenius Medical Care and CytoSorbents Expand Original Partnership and Add New Co-Marketing Agreement for Worldwide CytoSorb® Markets

PR Newswire Europe Non Regulatory January 11, 2017

CytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results

PR Newswire January 10, 2017

Fresenius Medical Care and CytoSorbents Expand Original Partnership and Add New Co-Marketing Agreement for Worldwide CytoSorb® Markets

PR Newswire January 9, 2017

CytoSorbents To Provide Corporate Update at Biotech Showcase 2017

PR Newswire January 3, 2017

CytoSorbents Announces First Sales of New CytoSorb® CPB Procedure Pack for Cardiac Surgery

PR Newswire December 20, 2016

CytoSorbents Receives $318,551 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program

PR Newswire December 12, 2016

CytoSorb® Attains Permanent, Dedicated Reimbursement Code in Core Market of Germany

PR Newswire December 7, 2016

CytoSorbents to Present at the LD Micro Main Event Investor Conference

PR Newswire December 2, 2016

CytoSorb® Selected for NICE MedTech Innovation Briefing in the United Kingdom

PR Newswire December 1, 2016

First Successful Treatment of Dengue Fever and Dengue Shock Syndrome Using CytoSorb®

PR Newswire November 22, 2016

CytoSorbents Reports Highlights from the SepsEast 2016 Critical Care Congress

PR Newswire November 17, 2016

Adrian Thomas Joins CytoSorbents to Drive Western European Sales

PR Newswire November 15, 2016